Log in

NYSEARCA:RXDProShares UltraShort Health Care Stock Price, Forecast & News

-0.38 (-2.86 %)
(As of 05/29/2020 04:00 PM ET)
Today's Range
Now: $12.92
50-Day Range
MA: $14.34
52-Week Range
Now: $12.92
Volume9,253 shs
Average Volume7,171 shs
Market Capitalization$2.08 million
P/E RatioN/A
Dividend Yield1.89%
ProShares UltraShort Health Care (the Fund) seeks daily investment results that correspond to twice (200%) the inverse (opposite) of the daily performance of the Dow Jones U.S. Health Care Index (the Index). The Fund intends to invest at least 80% of its net assets, including any borrowings for investment purposes, to investments that, in combination, have economic characteristics that are inverse to those of the Index. The Fund also intends to invest assets not invested in financial instruments, in debt instruments and/or money market instruments. The Fund intends to concentrate its investments in a particular industry or group of industries to approximately the same extent as the Index is so concentrated. ProShare Advisors LLC serves as the investment advisor to the Fund.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 3.2Dividend Strength: 1.7Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.97 out of 5 stars

Basic Details

Issuer ProShares
Fund NameProShares UltraShort Health Care
Tax ClassificationRegulated Investment Company
Inception Date1/30/2007
Fund ManagerMichael Neches, Tarak Dave

Fund Focus

Asset ClassEquity
BenchmarkDow Jones US Healthcare Index
FocusHealth Care
Development LevelDeveloped Markets
RegionNorth America

Fund Statistics

Assets Under Management$1.80 million
Average Daily Volume$8,288.00

ETF Expenses

Management Fee0.75%
Other Expenses2.74%
Total Expenses3.49%
Fee Waiver-2.54%
Net Expenses0.95%

Administrator, Advisor and Custodian

AdministratorJ.P. Morgan Investor Services Co.
AdvisorProShare Advisors LLC
CustodianJPMorgan Chase Bank, N.A.
DistributorSEI Investments Distribution Co.
Transfer AgentJPMorgan Chase Bank, N.A.
Lead Market MakerIMC Chicago

Receive RXD News and Ratings via Email

Sign-up to receive the latest news and ratings for RXD and its competitors with MarketBeat's FREE daily newsletter.

Currency Exposure of ProShares UltraShort Health Care (NYSEARCA:RXD)

ProShares UltraShort Health Care (NYSEARCA:RXD) Frequently Asked Questions

How has ProShares UltraShort Health Care's stock been impacted by COVID-19 (Coronavirus)?

ProShares UltraShort Health Care's stock was trading at $20.22 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, RXD shares have decreased by 36.1% and is now trading at $12.9201. View which stocks have been most impacted by Coronavirus.

How often does ProShares UltraShort Health Care pay dividends? What is the dividend yield for ProShares UltraShort Health Care?

ProShares UltraShort Health Care declared a quarterly dividend on Wednesday, March 25th. Investors of record on Thursday, March 26th will be paid a dividend of $0.0167 per share on Wednesday, April 1st. This represents a $0.07 annualized dividend and a dividend yield of 0.52%. The ex-dividend date is Wednesday, March 25th. View ProShares UltraShort Health Care's dividend history.

Has ProShares UltraShort Health Care been receiving favorable news coverage?

Media headlines about RXD stock have been trending very negative this week, according to InfoTrie Sentiment Analysis. The research group identifies positive and negative press coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. ProShares UltraShort Health Care earned a daily sentiment score of -3.4 on InfoTrie's scale. They also assigned press coverage about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an impact on the company's share price in the next several days. View the latest news aboutProShares UltraShort Health Care.

Who are ProShares UltraShort Health Care's key executives?

ProShares UltraShort Health Care's management team includes the following people:
  • Michael L. Sapir, Chairman of ProShares Trust (Age 57)
  • Louis M. Mayberg, President of ProShares Trust (Age 53)
  • Victor M. Frye Esq., Chief Compliance Officer and AML Officer of ProShares Trust (Age 56)
  • Simon D. Collier, Treasurer of ProShares Trust (Age 51)
  • Gary A. Casagrande, Assistant Treasurer of ProShares Trust (Age 40)
  • Charles S. Todd, Assistant Treasurer of ProShares Trust (Age 41)
  • Stephenie Adams, Acting Secretary of ProShares Trust (Age 43)
  • Gregory Pickard Esq., Assistant Secretary of ProShares Trust (Age 48)
  • Russell S. Reynolds III, Trustee of ProShares Trust (Age 55)
  • Michael C. Wachs, Trustee of ProShares Trust (Age 51)

What is ProShares UltraShort Health Care's stock symbol?

ProShares UltraShort Health Care trades on the New York Stock Exchange (NYSE)ARCA under the ticker symbol "RXD."

How do I buy shares of ProShares UltraShort Health Care?

Shares of RXD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is ProShares UltraShort Health Care's stock price today?

One share of RXD stock can currently be purchased for approximately $12.92.

How big of a company is ProShares UltraShort Health Care?

ProShares UltraShort Health Care has a market capitalization of $2.08 million.

What is ProShares UltraShort Health Care's official website?

The official website for ProShares UltraShort Health Care is www.proshares.com.

How can I contact ProShares UltraShort Health Care?

ProShares UltraShort Health Care's mailing address is SUITE 1000 7501 WISCONSIN AVENUE, BETHESDA, 20814, United States. The company can be reached via phone at +1-240-4976400.

This page was last updated on 5/31/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.